Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 25;12(3):289.
doi: 10.3390/ani12030289.

Can Procalcitonin Be Dosed in Bovine Milk Using a Commercial ELISA Kit?

Affiliations

Can Procalcitonin Be Dosed in Bovine Milk Using a Commercial ELISA Kit?

Valentina Meucci et al. Animals (Basel). .

Abstract

The aim was to evaluate the use of a bovine procalcitonin (PCT) ELISA kit (Cusabio, China) for assessing PCT in bovine milk samples. Validation was performed by using 10 plasma and corresponding milk samples from mastitic cows. The limit of detection (LOD) was calculated. The coefficient of variation (CV%) of the readings of five plasma samples measured five times in the same plate (intra-assay) and the CV% of the same five samples read five times in three separate plates was evaluated. Parallelism was determined by serial twofold dilutions of five plasma and corresponding milk samples. Milk samples were analyzed with and without centrifugation. Regarding plasma PCT, the method presented an inter- and intra-CV < 23.7% and parallelism had very good recovery values. The ELISA kit studied can measure bovine plasma PCT concentrations. The kit antibodies fail in binding PCT in milk samples because all centrifuged milk samples showed a lower LOD than blank samples. Only three uncentrifuged milk samples showed measurable PCT concentrations. Due to these results, the commercial ELISA kit investigated could not be employed for the detection of PCT in milk samples.

Keywords: ELISA kit; bovine; mastitis; milk; plasma; procalcitonin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Petersson-Wolfe C.S., Leslie K.E., Swartz T.H. An update on the effect of clinical mastitis on the welfare of dairy cows and potential therapies. Vet. Clin. Food Anim. Pract. 2018;34:525–535. doi: 10.1016/j.cvfa.2018.07.006. - DOI - PubMed
    1. Olde Riekerink R.G., Barkema H.W., Kelton D.F., Scholl D.T. Incidence rate of clinical mastitis on Canadian dairy farms. J. Dairy Sci. 2008;91:1366–1377. doi: 10.3168/jds.2007-0757. - DOI - PubMed
    1. Ericsson Unnerstad H., Lindberg A., Persson Waller K., Ekman T., Artursson K., Nilsson-Ost M., Bengtsson B. Microbial aetiology of acute clinical mastitis and agent-specific risk factors. Vet. Microbiol. 2009;137:90–97. doi: 10.1016/j.vetmic.2008.12.005. - DOI - PubMed
    1. Persson K., Amolina B., Jonsson P. Inflammation in the bovine teat cistern induced by Staphylococcus aureus. J. Vet. Med. B. 1995;42:435–442. doi: 10.1111/j.1439-0450.1995.tb00733.x. - DOI - PubMed
    1. Hiss S., Mielenz M., Bruckmaier R.M., Sauerwein H. Haptoglobin concentrations in blood and milk after endotoxin challenge and quantification of mammary Hp mRNA expression. J. Dairy Sci. 2004;87:3778–3784. doi: 10.3168/jds.S0022-0302(04)73516-X. - DOI - PubMed

LinkOut - more resources